Researchers have put great hope that a new drug will prove successful in treating emerging coronavirus patients, but a Chinese study in this regard has blown out their hopes. The study, published in details of the American newspaper "The New York Times," said that the treatment did not succeed in helping patients recover. Researchers wrote in the New England Journal of Medicine, they have not seen any benefit in the new treatment. The study examined the effect of the drug known as "Kaletra", which is a combination of two antivirals that are usually used in AIDS cases. The test included 199 adult patients between the ages of 48 and 68 who were being treated with viruskrona in a hospital in Wuhan, China.
For 14 days, half of these patients were given drugs, but they did not reduce pain and did not prevent deaths.
In contrast, the other half received traditional care that focused on treating symptoms of the disease, such as medical intervention to combat pneumonia.
Although the results were disappointing, the researchers, the treatment developers, said that the study was "not the final word," calling for more tests in this regard.
The largest drug companies around the world are racing to make a drug that can defeat the Corona virus, which has killed about 9,000 people and infected more than 220,000 in more than 120 countries.
About 50 drugs are being developed and tested to combat the virus, also known as "Covid 19".
The World Health Organization says it has not yet approved any proven treatment for the virus, and there is no vaccine to prevent it.
Comments
Post a Comment